BANK OF MONTREAL /CAN/ - SAGENT PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$551,000
+26.1%
36,720
+2.2%
0.00%
Q1 2016$437,000
-9.0%
35,946
+19.2%
0.00%
-100.0%
Q4 2015$480,000
+26.3%
30,163
+21.5%
0.00%0.0%
Q3 2015$380,000
-49.3%
24,816
-19.5%
0.00%0.0%
Q2 2015$750,000
+34.9%
30,829
+29.1%
0.00%0.0%
Q1 2015$556,000
+54.0%
23,879
+66.2%
0.00%
Q4 2014$361,000
-7.4%
14,365
+14.4%
0.00%
Q3 2014$390,000
+18.9%
12,556
-1.3%
0.00%
Q2 2014$328,000
+15.1%
12,718
+4.5%
0.00%
Q1 2014$285,000
+5.2%
12,173
+13.9%
0.00%
Q4 2013$271,000
+39.7%
10,683
+12.5%
0.00%
Q3 2013$194,0009,4970.00%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 462,824$7,364,0008.63%
HealthCor Management, L.P. 1,750,000$27,843,0001.69%
ACUTA CAPITAL PARTNERS, LLC 144,667$2,302,0001.10%
THB ASSET MANAGEMENT 615,546$9,793,0001.05%
Penn Capital Management Company, LLC 1,399,205$22,261,0000.98%
Tamarack Advisers, LP 450,000$7,160,0000.94%
Piermont Capital Management Inc. 139,020$2,212,0000.70%
JW Asset Management, LLC 101,630$1,617,0000.60%
SECTORAL ASSET MANAGEMENT INC 810,362$12,893,0000.55%
Glacier Peak Capital LLC 50,000$796,0000.51%
View complete list of SAGENT PHARMACEUTICALS INC shareholders